EUSA Pharma is a global biopharmaceutical company based in the United Kingdom. The company is committed to transforming the lives of people affected by rare diseases or cancer. They continuously strive to bring innovative medicines to people with few or no treatment options available.
Teams at EUSA Germany turned to Arthur’s VR office solution to overcome the limitation of 2D tools and harness the power and immersive nature of VR technology to hold meetings with remotely located healthcare practitioners. VR enabled EUSA to create engaging formats to facilitate expert dialogue.
The diseases treated by EUSA are highly complex in nature and rare in occurrence. One such disease is Neuroblastoma, a type of cancer, often found in the small glands on top of the kidneys (adrenal glands). This disease is most commonly found in children aged five or younger.
To create effective solutions for such diseases, EUSA conducts regular meetings with pediatric oncologists and nursing staff. The company uses Arthur's virtual offices for conducting scientific events where they invite specialized doctors to talk about best practices for treating neuroblastomas in children. EUSA understands the patient's concerns and how they would like to understand the disease in its whole complexity before enrolling for a special rare treatment regimen. EUSA is practising scientific conversation in VR by constructing a customized room filled with 3D models of the human body and visualization of the disease. The opportunity to interact with 3D models enables the team to understand and explain the disease clearly. In these customized rooms, the intuitive nature of Arthur enabled EUSA to customize the virtual rooms according to the topic at hand. They spawned multiple presentations to present various topics and used the audio zone features for having breakout conversations. Using pinboards and sticky notes, teams at EUSA held multiple brainstorming sessions in Arthur.
Conducting VR meetings with doctors not only enhances communication clarity but also saves the company an ample amount of time and costs associated with travel. The specialist doctors also prefer virtual meetings since it reduces their need to travel without compromising the quality of the exchange. It reflects the need for strong interaction between therapy centres with adequate technology. Personal meetings without travelling strengthen the interaction to provide optimal treatment per patient in this dramatic indication.
In the future, EUSA plans to hold larger events in VR to enable the productive collaboration of healthcare practitioners from across the world. By adopting VR for engaging with key opinion leaders in the niche field of rare diseases, EUSA is attempting to establish a better understanding in the community and develop a smoother customer journey.
‘Arthur provides us an innovative and efficient way to connect with healthcare experts on a national and international level. The vast customisable virtual spaces enable us to dive deeper into the complex scientific l aspects and talk about best practices for treating a rare disease under optimal and harmonized conditions to support affected children and relatives in a best manner.
Jörg Camp, Senior Brand Manager DACH, EUSA